Characterization of anti-FCRL1 mAbs
| Name . | Isotope . | Affinity of Kd (nM) . | Topographical epitope . |
|---|---|---|---|
| E3 | γ1 × κ | 4.2 | I |
| E6 | γ1 × κ | 6.2 | II |
| E7 | γ1 × κ | 5.5 | II |
| E9 | γ1 × κ | 5.1 | III |
| E12 | γ1 × κ | 6.8 | IV |
| E13 | γ1 × κ | 5.4 | III |
| E14 | γ2a × κ | 6.1 | III |
| Name . | Isotope . | Affinity of Kd (nM) . | Topographical epitope . |
|---|---|---|---|
| E3 | γ1 × κ | 4.2 | I |
| E6 | γ1 × κ | 6.2 | II |
| E7 | γ1 × κ | 5.5 | II |
| E9 | γ1 × κ | 5.1 | III |
| E12 | γ1 × κ | 6.8 | IV |
| E13 | γ1 × κ | 5.4 | III |
| E14 | γ2a × κ | 6.1 | III |
Reactivity to FcRL1 was positive in all cases. Cross-reactivity to FcRL2-6 in ELISA and FACS was negative in all cases.